Delivery Order SPE2DB22D1017-SPE2DB24FF7TF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.10 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of Veltassa 8.4 GM powder packets. The $1,547.26 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 22, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veltassa 16.8 GM Powder Packets. The contract has a ceiling value of $2,827.08 and a performance period through April 12, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Veltassa 8.4 GM Powder Packet 30S. The $1,050.22 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 8, 2024 with a completion date of July 9, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 28, 2022. The $2,177.29 delivery order is for the supply of Veltassa 16.8 GM Powder Packets, a specialty medication. The contract has a firm fixed price and an ultimate completion date of June 29, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Veltassa 8.4 GM powder packets. The $12,655.12 firm-fixed-price delivery order contract has an ultimate completion date of July 31, 2024 and is not associated with a set-aside program. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, through which this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,456.26 Firm Fixed Price Delivery Order, awarded on December 9, 2024, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $5,782.31 for the supply of the pharmaceutical product Veltassa 25.2 GM Powder Packet 30S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a period of performance through March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- This federal contract award, valued at $1,082.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order to supply the medication Veltassa 25.2 GM Powder Packet 30S. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7TFDelivery Order
This federal contract award is for the delivery of Veltassa 8.4 GM Powder Packets in quantities of 30 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $2,648.31 and an ultimate completion date of May 16, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/15/24 |